Sivik Global Healthcare LLC Trims Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Sivik Global Healthcare LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 20.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,000 shares of the company's stock after selling 5,000 shares during the quarter. HCA Healthcare comprises 3.4% of Sivik Global Healthcare LLC's holdings, making the stock its 11th biggest position. Sivik Global Healthcare LLC's holdings in HCA Healthcare were worth $8,129,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Bangor Savings Bank increased its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company's stock valued at $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC lifted its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after buying an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare during the second quarter worth about $33,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock traded down $3.96 during midday trading on Thursday, hitting $345.36. 1,835,701 shares of the company's stock were exchanged, compared to its average volume of 1,183,271. The company has a market cap of $87.48 billion, a P/E ratio of 15.79, a PEG ratio of 1.35 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a 50-day moving average price of $387.05 and a two-hundred day moving average price of $357.11. HCA Healthcare, Inc. has a 52-week low of $237.57 and a 52-week high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 11.85%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research analyst reports. Royal Bank of Canada upped their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an "outperform" rating in a research report on Friday, August 23rd. UBS Group boosted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a "buy" rating in a research report on Wednesday, August 14th. Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a research note on Thursday, August 29th. Oppenheimer lifted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Finally, KeyCorp dropped their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a research note on Monday, October 28th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.